5.1 C
New Delhi
Monday, January 12, 2026

CIPLA LIMITED APPOINTS ACHIN GUPTA AS MD & GLOBAL CEO

Achin Gupta appointed MD & Global CEO of Cipla Limited, effective April 1, 2026. With over 20 years of experience, he has driven Cipla’s growth and transformation. As current Global COO, he oversees a $3 billion portfolio, driving operational excellence and innovation. Expected to accelerate Cipla’s mission to make healthcare more accessible and affordable.

Cipla Limited, a leading global pharmaceutical company, has announced the appointment of Achin Gupta as its Managing Director & Global Chief Executive Officer (MD & GCEO), effective April 1, 2026. This strategic move marks a significant milestone in Cipla’s leadership evolution, underscoring the company’s commitment to strengthening its global leadership and advancing its mission of providing accessible, high-quality, and innovative healthcare solutions worldwide.

Achin, a seasoned healthcare professional with over two decades of experience, has played a central role in driving Cipla’s growth and transformation. As the current Global Chief Operating Officer, he has overseen a global commercial portfolio exceeding USD 3 billion, steering initiatives that deliver operational excellence, digital transformation, and patient-centric innovation. His leadership has been instrumental in accelerating revenue growth, enhancing market share, and fostering a culture of agility and performance.

Prior to joining Cipla, Achin held leadership roles at Glenmark Pharmaceuticals, where he spearheaded business expansion across Europe, LATAM, the Middle East, and the Asia-Pacific region, transforming the company into a diversified branded and OTC business. His earlier career at Abbott Laboratories provided a strong foundation in global business strategy and operational excellence.

Cipla’s Board of Directors is confident that Achin’s leadership will further strengthen the company’s position as a global healthcare leader, driving growth, innovation, and patient-centric solutions. His appointment is expected to accelerate Cipla’s mission to make healthcare more accessible and affordable, while delivering sustainable value to stakeholders.


Discover more from Creative Brands

Subscribe to get the latest posts sent to your email.

spot_img

Must Read

- Advertisement -spot_img

Archives

Related news

- Advertisement -spot_imgspot_img

Discover more from Creative Brands

Subscribe now to keep reading and get access to the full archive.

Continue reading